Literature DB >> 25848386

Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel.

Ashkan Faridi1, Ali Farahnak1, Taghi Golmohammadi2, Mohammadreza Eshraghian3, Yosef Sharifi1, Mohammadbagher Molaei Rad1.   

Abstract

BACKGROUND: The aim of this study was to evaluate the protein spots of excretory - secretory products of Fasciola hepatica using two dimension electrophoresis method in the presence and absence of triclabendazole drug which can be considered to detect the target protein of the drug.
METHODS: F. hepatica parasites were collected from infected cattle livers, divided in two groups and cultivated in RPMI 1640 medium. First group was treated with triclabendazole (TCBZ) and second group considered as control. The excretory-secretory (ES) products of each group were separated and total protein determined by Bradford method. To provide proteome spots, the ES proteins were precipitated and two dimension electrophoresis (2-DE) gel prepared. Protein amounts of two groups were compared using the statistical t-test and protein spots from 2-DE in test and control groups were also statistically analyzed. The protein spots of gels were identified by using protein database.
RESULTS: The t-test showed a significant increase of total proteins in treated group (P<0.5). The protein spots count in the control group was less than test group however statistically not significant (p>0.05). Cathepsin L- protein (MW 36.7 pH 5.34), 14-3-3 epsilon 2 isoform (MW 28.2 pH 5.36), Cathepsin L1D (MW 36.5 pH 5.8) and Cathepsin L1D (MW 36.6 pH 6.26) were identified in test group.
CONCLUSION: It seems that, these results can be considered to determine the proteins which the drug acts as a target on them.

Entities:  

Keywords:  Fasciola hepatica; Triclabendazole Proteome; Two - dimensional electrophoresis (2-DE)

Year:  2014        PMID: 25848386      PMCID: PMC4386040     

Source DB:  PubMed          Journal:  Iran J Parasitol        ISSN: 1735-7020            Impact factor:   1.012


  9 in total

1.  Excretory-secretory products of larval Fasciola hepatica investigated using a two-dimensional proteomic approach.

Authors:  Benjamin E F Gourbal; François Guillou; Guillaume Mitta; Pierre Sibille; André Thèron; Jean-Pierre Pointier; Christine Coustau
Journal:  Mol Biochem Parasitol       Date:  2008-05-08       Impact factor: 1.759

Review 2.  Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives.

Authors:  Haleem Issaq; Timothy Veenstra
Journal:  Biotechniques       Date:  2008-04       Impact factor: 1.993

3.  Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host.

Authors:  E Toner; G P Brennan; R E B Hanna; H W Edgar; I Fairweather
Journal:  Vet Parasitol       Date:  2010-05-16       Impact factor: 2.738

4.  Proteomic analysis of Fasciola hepatica excretory-secretory products.

Authors:  J R Jefferies; A M Campbell; A J van Rossum; J Barrett; P M Brophy
Journal:  Proteomics       Date:  2001-09       Impact factor: 3.984

5.  Human and animal fascioliasis in Mazandaran province, northern Iran.

Authors:  A S Moghaddam; J Massoud; M Mahmoodi; A H Mahvi; M V Periago; P Artigas; M V Fuentes; M D Bargues; S Mas-Coma
Journal:  Parasitol Res       Date:  2004-07-31       Impact factor: 2.289

6.  The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica.

Authors:  A W Stitt; I Fairweather
Journal:  Parasitology       Date:  1994-06       Impact factor: 3.234

Review 7.  The present status of human helminthic diseases in Iran.

Authors:  M B Rokni
Journal:  Ann Trop Med Parasitol       Date:  2008-06

8.  Comparative proteomics of excretory-secretory proteins released by the liver fluke Fasciola hepatica in sheep host bile and during in vitro culture ex host.

Authors:  Russell M Morphew; Hazel A Wright; E James LaCourse; Debra J Woods; Peter M Brophy
Journal:  Mol Cell Proteomics       Date:  2007-02-17       Impact factor: 5.911

9.  Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano.

Authors:  Fidel Villegas; René Angles; René Barrientos; Gary Barrios; María Adela Valero; Kamal Hamed; Heiner Grueninger; Steven K Ault; Antonio Montresor; Dirk Engels; Santiago Mas-Coma; Albis Francesco Gabrielli
Journal:  PLoS Negl Trop Dis       Date:  2012-08-07
  9 in total
  3 in total

1.  Fasciola Hepatica Mimicking Malignancy on 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography.

Authors:  Erdem Sürücü; Yusuf Demir; Ahmet C Dülger; Abdüssamed Batur; Şehmus Ölmez; Mehmet T Kitapçı
Journal:  Mol Imaging Radionucl Ther       Date:  2016-10-05

2.  A Comparison between the Effects of Albendazole and Mebendazole on the Enzymatic Activity of Excretory / Secretory Products of Echinococcus granulosus Protoscoleces in Vitro.

Authors:  Seyed Jafar Adnani Sadati; Ali Farahnak; Mohammad Bagher Molaei Rad; Abolfazl Golestani; Mohammad Reza Eshraghiyan
Journal:  Iran J Public Health       Date:  2016-02       Impact factor: 1.429

3.  Protein Detection of Excretory-Secretory Products and Somatic Extracts from Fasciola hepatica and F. gigantica Using Two-Dimensional Electrophoresis.

Authors:  Afshin Rasouli; Ali Farahnak; Hakimeh Zali; Mostafa Rezaeian; Abolfazl Golestani; Mohammad Bagher Molaei Rad
Journal:  Iran J Parasitol       Date:  2019 Jul-Sep       Impact factor: 1.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.